Loading company…
Uncommon Therapeutics develops treatments for rare neurodevelopmental diseases, including Rett Syndrome.
Founded in 2024 and based in San Francisco, Uncommon Therapeutics develops therapeutics for rare neurodevelopmental monogenic diseases, particularly Rett Syndrome. Its approach combines multiple technologies and treatment modalities. The company raised funding from Pioneer Fund in March 2025 to support therapeutic development.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in